FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385797639> ?p ?o ?g. }

• W4385797639 endingPage "623" @default.
• W4385797639 startingPage "617" @default.
• W4385797639 abstract "During Intensive Care Unit (ICU) admission, patients demonstrate up to 15% muscle loss per week, contributing to neuromuscular weakness, complicating recovery and delaying return to daily life. Biomarkers for muscle loss could aid in early detection of patients at risk and help guide resources to mitigate muscle loss, e.g. physical therapy and protein supplementation.To explore serum biomarkers for muscle mass and muscle loss in ICU patients using a metabolomics approach.Mechanically ventilated patients with an unplanned ICU admission between June and December 2021 were prospectively studied. The cross-sectional area of the rectus femoris muscle was assessed using ultrasound (RFcsa) and 188 serum metabolites were assessed using the Biocrates™ AbsoluteIDQ p180 kit for targeted metabolomics. Patients were eligible for analysis when a serum sample drawn within 5 days of ICU admission and at least 1 RFcsa were available. In patients with sequential RFcsa measurements, muscle loss was defined as the negative slope of the regression line fitted to the RFcsa measurements per patient in the first 10 days of ICU admission. Correlations between baseline metabolite concentrations and baseline muscle mass, as well as between baseline metabolite concentrations and muscle loss were assessed using Pearson's test for correlations. To correct for multiple testing, the Benjamini-Hochberg procedure was used.Seventeen patients were eligible for analysis. Mean age was 62 (SD ± 9) years and the cohort was predominantly male (76%). Four metabolites correlated with baseline muscle mass: creatinine (R = 0.5, p = 0.041), glycerophospholipid PC_ae_C30_0 (R = 0.5, p = 0.034) and two acylcarnitines: C14_2 (R = 0.5, p = 0.042) and C10_2 (R = 0.5, p = 0.049). For muscle loss, significant associations were found for histidine (R = -0.8, p = 0.002) and three glycerophospholipids; PC_aa_C40_2 (R = 0.7, p = 0.015), PC_ae_C40_1 (R = 0.6, p = 0.032) and PC_aa_C42_1 (R = 0.6, p = 0.037). After correction for multiple testing, no significant associations remained.This exploratory analysis found certain metabolites to be associated with muscle mass and muscle loss. Future research, specifically addressing these metabolites is necessary to confirm or refute an association with muscle loss and determine their role as potential muscle loss marker." @default.
• W4385797639 created "2023-08-15" @default.
• W4385797639 creator A5032667769 @default.
• W4385797639 creator A5034638705 @default.
• W4385797639 creator A5045787854 @default.
• W4385797639 creator A5049731825 @default.
• W4385797639 creator A5049871946 @default.
• W4385797639 creator A5051026174 @default.
• W4385797639 creator A5066273975 @default.
• W4385797639 creator A5081927218 @default.
• W4385797639 creator A5089818498 @default.
• W4385797639 creator A5092635550 @default.
• W4385797639 date "2023-10-01" @default.
• W4385797639 modified "2023-10-02" @default.
• W4385797639 title "Serum metabolomics analysis for quantification of muscle loss in critically ill patients: An explorative study" @default.
• W4385797639 cites W1137757416 @default.
• W4385797639 cites W1739529336 @default.
• W4385797639 cites W1956386905 @default.
• W4385797639 cites W2034978050 @default.
• W4385797639 cites W2058846847 @default.
• W4385797639 cites W2064612269 @default.
• W4385797639 cites W2109896310 @default.
• W4385797639 cites W2111370164 @default.
• W4385797639 cites W2111861407 @default.
• W4385797639 cites W2118240638 @default.
• W4385797639 cites W2119096766 @default.
• W4385797639 cites W2119473444 @default.
• W4385797639 cites W2136529928 @default.
• W4385797639 cites W2144982043 @default.
• W4385797639 cites W2145796234 @default.
• W4385797639 cites W2194890007 @default.
• W4385797639 cites W2206656449 @default.
• W4385797639 cites W2295362613 @default.
• W4385797639 cites W2297617409 @default.
• W4385797639 cites W2316676403 @default.
• W4385797639 cites W2318180844 @default.
• W4385797639 cites W2524082071 @default.
• W4385797639 cites W2752446102 @default.
• W4385797639 cites W2763774549 @default.
• W4385797639 cites W2769276186 @default.
• W4385797639 cites W2996776413 @default.
• W4385797639 cites W3000788519 @default.
• W4385797639 cites W3007048016 @default.
• W4385797639 cites W3021952782 @default.
• W4385797639 cites W3031319756 @default.
• W4385797639 cites W3048158548 @default.
• W4385797639 cites W3084022240 @default.
• W4385797639 cites W3108691631 @default.
• W4385797639 cites W3158308182 @default.
• W4385797639 cites W3160842077 @default.
• W4385797639 cites W3165748224 @default.
• W4385797639 cites W3214526323 @default.
• W4385797639 cites W4200350197 @default.
• W4385797639 cites W4281400014 @default.
• W4385797639 cites W4282943935 @default.
• W4385797639 cites W4313522108 @default.
• W4385797639 doi "https://doi.org/10.1016/j.clnesp.2023.08.012" @default.
• W4385797639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37739714" @default.
• W4385797639 hasPublicationYear "2023" @default.
• W4385797639 type Work @default.
• W4385797639 citedByCount "0" @default.
• W4385797639 crossrefType "journal-article" @default.
• W4385797639 hasAuthorship W4385797639A5032667769 @default.
• W4385797639 hasAuthorship W4385797639A5034638705 @default.
• W4385797639 hasAuthorship W4385797639A5045787854 @default.
• W4385797639 hasAuthorship W4385797639A5049731825 @default.
• W4385797639 hasAuthorship W4385797639A5049871946 @default.
• W4385797639 hasAuthorship W4385797639A5051026174 @default.
• W4385797639 hasAuthorship W4385797639A5066273975 @default.
• W4385797639 hasAuthorship W4385797639A5081927218 @default.
• W4385797639 hasAuthorship W4385797639A5089818498 @default.
• W4385797639 hasAuthorship W4385797639A5092635550 @default.
• W4385797639 hasConcept C126322002 @default.
• W4385797639 hasConcept C2776376669 @default.
• W4385797639 hasConcept C2776418732 @default.
• W4385797639 hasConcept C2777515770 @default.
• W4385797639 hasConcept C2778230138 @default.
• W4385797639 hasConcept C2780306776 @default.
• W4385797639 hasConcept C2992343062 @default.
• W4385797639 hasConcept C71924100 @default.
• W4385797639 hasConcept C72563966 @default.
• W4385797639 hasConcept C99508421 @default.
• W4385797639 hasConceptScore W4385797639C126322002 @default.
• W4385797639 hasConceptScore W4385797639C2776376669 @default.
• W4385797639 hasConceptScore W4385797639C2776418732 @default.
• W4385797639 hasConceptScore W4385797639C2777515770 @default.
• W4385797639 hasConceptScore W4385797639C2778230138 @default.
• W4385797639 hasConceptScore W4385797639C2780306776 @default.
• W4385797639 hasConceptScore W4385797639C2992343062 @default.
• W4385797639 hasConceptScore W4385797639C71924100 @default.
• W4385797639 hasConceptScore W4385797639C72563966 @default.
• W4385797639 hasConceptScore W4385797639C99508421 @default.
• W4385797639 hasFunder F4320311402 @default.
• W4385797639 hasFunder F4320320300 @default.
• W4385797639 hasFunder F4320320879 @default.
• W4385797639 hasFunder F4320334685 @default.
• W4385797639 hasFunder F4320338395 @default.
• W4385797639 hasLocation W43857976391 @default.

• next